当前位置:首页 - 行情中心 - 常山药业(300255) - 财务分析 - 现金流量表

常山药业

(300255)

  

流通市值:373.29亿  总市值:373.87亿
流通股本:9.18亿   总股本:9.19亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金226,574,610.71928,888,642.49768,522,243.45548,877,594.72
  收到的税费返还1,440.878,198,288.88,170,495.718,165,041.85
  收到其他与经营活动有关的现金10,263,936.2329,657,784.5232,326,771.1721,452,714.79
  经营活动现金流入小计236,839,987.81966,744,715.81809,019,510.33578,495,351.36
  购买商品、接受劳务支付的现金141,459,135.22614,771,064.29430,909,663.99239,851,756.74
  支付给职工以及为职工支付的现金41,720,214.55154,736,779.25122,148,023.5881,569,342.45
  支付的各项税费4,047,709.237,176,717.3334,179,936.7325,288,771.25
  支付其他与经营活动有关的现金29,404,777.22104,377,276.6379,431,136.1858,577,680.74
  经营活动现金流出小计216,631,836.19911,061,837.5666,668,760.48405,287,551.18
  经营活动产生的现金流量净额20,208,151.6255,682,878.31142,350,749.85173,207,800.18
二、投资活动产生的现金流量:
  收到的其他与投资活动有关的现金100,020,000157,263,980106,503,980106,060,000
  投资活动现金流入小计100,020,000157,263,980106,503,980106,060,000
  购建固定资产、无形资产和其他长期资产支付的现金29,427,247.04123,359,028.0472,037,176.7747,570,898.22
  支付其他与投资活动有关的现金100,017,000157,215,000106,568,000106,283,000
  投资活动现金流出小计129,444,247.04280,574,028.04178,605,176.77153,853,898.22
  投资活动产生的现金流量净额-29,424,247.04-123,310,048.04-72,101,196.77-47,793,898.22
三、筹资活动产生的现金流量:
  取得借款收到的现金800,549,551.292,200,738,918.631,984,038,918.63965,324,418.63
  收到其他与筹资活动有关的现金23,665,200411,046,00084,000,00064,000,000
  筹资活动现金流入小计824,214,751.292,611,784,918.632,068,038,918.631,029,324,418.63
  偿还债务支付的现金675,515,428.262,239,344,873.111,954,652,648.581,062,423,078.52
  分配股利、利润或偿付利息支付的现金28,474,359.64118,692,653.4789,652,045.4359,262,110.83
  支付其他与筹资活动有关的现金54,860,432312,291,15985,593,00055,182,000
  筹资活动现金流出小计758,850,219.92,670,328,685.582,129,897,694.011,176,867,189.35
  筹资活动产生的现金流量净额65,364,531.39-58,543,766.95-61,858,775.38-147,542,770.72
四、汇率变动对现金及现金等价物的影响-729,624.22,282,864.872,765,798.572,654,762.67
五、现金及现金等价物净增加额55,418,811.77-123,888,071.8111,156,576.27-19,474,106.09
  加:期初现金及现金等价物余额111,998,708.81235,886,780.62235,886,780.62235,886,780.62
  期末现金及现金等价物余额167,417,520.58111,998,708.81247,043,356.89216,412,674.53
补充资料:
  净利润--367,461,129.51--36,220,597.35
  资产减值准备-166,861,830.69--18,787,985.13
  固定资产和投资性房地产折旧-58,346,528.92-28,894,830.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-58,346,528.92-28,894,830.57
  无形资产摊销-9,441,670.58-4,735,575.43
  长期待摊费用摊销-1,685,557.47-1,620,735.06
  处置固定资产、无形资产和其他长期资产的损失-7,377.37--17,641.19
  固定资产报废损失-221,024.8-29,659.01
  财务费用-94,573,966.98-48,924,439.19
  投资损失--1,671,766.1--
  递延所得税-2,425,252.92-3,078,696.67
  其中:递延所得税资产减少-2,467,654.26-3,099,897.34
    递延所得税负债增加--42,401.34--21,200.67
  存货的减少-44,361,206.22-126,327,489.38
  经营性应收项目的减少-12,286,062.9--124,267,569.38
  经营性应付项目的增加-32,315,828.61-137,691,798.4
  现金的期末余额-111,998,708.81-216,412,674.53
  减:现金的期初余额-235,886,780.62-235,886,780.62
  现金及现金等价物的净增加额--123,888,071.81--19,474,106.09
公告日期2026-04-292026-04-292025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑